MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 16, 2004; DOI: 10.1124/mol.104.002287


0026-895X/04/6604-1029-1034$20.00
Mol Pharmacol 66:1029-1034, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002287v1
66/4/1029    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, S.
Right arrow Articles by Kozasa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, S.
Right arrow Articles by Kozasa, T.

Critical Role of Lysine 204 in Switch I Region of G{alpha}13 for Regulation of p115RhoGEF and Leukemia-Associated RhoGEF

Susumu Nakamura1, Barry Kreutz, Shihori Tanabe, Nobuchika Suzuki2, and Tohru Kozasa

Department of Pharmacology, University of Illinois College of Medicine, Chicago, Illinois

Heterotrimeric G proteins of the G12 family regulate the Rho GTPase through RhoGEFs that contain an amino-terminal regulator of G protein signaling (RGS) domain (RGS-RhoGEFs). Direct regulation of the activity of RGS-RhoGEFs p115 or leukemia-associated RhoGEF (LARG) by G{alpha}13 has previously been demonstrated. However, the precise biochemical mechanism by which G{alpha}13 stimulates the RhoGEF activity of these proteins has not yet been well understood. Based on the crystal structure of G{alpha}i1 in complex with RGS4, we mutated the G{alpha}13 residue lysine 204 to alanine (G{alpha}13K204A) and characterized the effect of this mutation in its regulation of RGS-RhoGEFs p115 or LARG. Compared with wild-type G{alpha}13, G{alpha}13K204A induced much less serum-response factor activation when expressed in HeLa cells. Recombinant G{alpha}13K204A exhibits normal function in terms of nucleotide binding, basal GTP hydrolysis, and formation of heterotrimer with {beta}{gamma}. We found that lysine 204 of G{alpha}13 is important for interaction with the RGS domain of p115 or LARG and for the GTPase-activating protein activity of these proteins. In addition, the K204A mutation of G{alpha}13 impaired its regulation of the RhoGEF activity of p115 or LARG. We conclude that lysine 204 of G{alpha}13 is important for interaction with RGS-RhoGEFs and is critically involved in the regulation of their activity.


Received May 3, 2004; accepted July 13, 2004

Address correspondence to: Dr. Tohru Kozasa, 835 South Wolcott Ave., M/C 868, Chicago, IL 60612. E-mail: tkozas{at}uic.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Suzuki, K. Tsumoto, N. Hajicek, K. Daigo, R. Tokita, S. Minami, T. Kodama, T. Hamakubo, and T. Kozasa
Activation of Leukemia-associated RhoGEF by G{alpha}13 with Significant Conformational Rearrangements in the Interface
J. Biol. Chem., February 20, 2009; 284(8): 5000 - 5009.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Rojas, M. E. Yohe, S. Gershburg, T. Kawano, T. Kozasa, and J. Sondek
G{alpha}q Directly Activates p63RhoGEF and Trio via a Conserved Extension of the Dbl Homology-associated Pleckstrin Homology Domain
J. Biol. Chem., October 5, 2007; 282(40): 29201 - 29210.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Huang, L. Dong, T. Kozasa, and G. C. Le Breton
Signaling through G{alpha}13 Switch Region I Is Essential for Protease-activated Receptor 1-mediated Human Platelet Shape Change, Aggregation, and Secretion
J. Biol. Chem., April 6, 2007; 282(14): 10210 - 10222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. E. Meigs, J. Juneja, C. T. DeMarco, L. N. Stemmle, D. D. Kaplan, and P. J. Casey
Selective Uncoupling of G{alpha}12 from Rho-mediated Signaling
J. Biol. Chem., May 6, 2005; 280(18): 18049 - 18055.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics